Comparison between a 1.92-μm fiber laser and a standard HF-dissection device for nephron-sparing kidney resection in a porcine in vivo study.
Nephron-sparing surgery was performed in a porcine model with a 1.92-μm fiber laser dissection device in comparison to a standard high-frequency dissection device. In nine pigs, general anesthesia and a median laparotomy were performed to expose both kidneys. On six kidneys (three HF and three laser) a partial renal parenchyma resection of the lower pole without opening of the renal pelvis was performed (group A). On 12 kidneys (four HF and eight laser), a hemi nephrectomy with opening of the renal pelvis was performed (group B). Total resection time including hemostasis of the remaining tissue was 501 ± 394 s in group "A-laser " vs. 176 ± 139 s in group "A-HF". For the group "B", the total resection time was 1174 ± 501 s (B laser) vs. 960 ± 407 s (B-HF). Blood loss was 28 ± 22 ml in group "A laser " vs. 15 ± 15 ml in group "A-HF". In group "B", the blood loss was 98 ± 73 ml (B laser) vs. 137 ± 118 ml (B-HF). No ischemic time for the kidneys was needed in group "A" for both dissection devices. In group "B", ischemia of the kidneys was performed three times during the eight laser procedures (420 ± 60 s) and only once at the four HF procedures (1,260 s). Healing process was observed over 4-6 weeks, survival rate was 100%, and no renal fistulas were found after the survival period. In conclusion, no significant differences were found between the compared dissection devices. However, the laser system with the flexible transmission fiber may have an advantage for a laparoscopic approach by steerable instruments.
Institute of Biomedical Optics (BMO), University of Lübeck, Peter Monnik Weg 4, 23538, Lübeck, Germany. theisen@bmo.uni-luebeck.de
Dirk
D
Theisen-Kunde
Sönke
S
Tedsen
Christian
C
Doehn
Dieter
D
Jocham
Ingo
I
Kausch von Schmeling
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000601:surgery*; D006487:Hemostasis; D066298:In Vitro Techniques; D007668:Kidney / Q000601:surgery*; D007680:Kidney Neoplasms / Q000601:surgery*; D053685:Laser Therapy / Q000295:instrumentation* / Q000379:methods; D013552:Swine
J Urol. 1985 Jun;133(6):1108-11
3839026
J Endourol. 2002 Dec;16(10):749-53
12542878
J Endourol. 2007 Sep;21(9):1107-11
17941795
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
19474385
J Endourol. 2002 Jun;16(5):289-92
12184078
J Urol. 2008 Apr;179(4):1227-33; discussion 1233-4
18280512
J Urol. 2007 Feb;177(2):471-6
17222613
J Endourol. 2008 Mar;22(3):403-8
18355135
Appl Opt. 2002 Sep 20;41(27):5797-803
12269579
Eur Urol. 2009 Apr;55(4):836-50
19168276
Eur Urol. 2007 Mar;51(3):749-54
16806667
JSLS. 2004 Jan-Mar;8(1):51-5
14974664
J Urol. 2009 Sep;182(3):866-72
19616229
J Endourol. 1998 Oct;12(5):441-4
9847067
J Endourol. 2006 Dec;20(12):1096-100
17206910
Arch Esp Urol. 2008 Nov;61(9):1126-9
19140596
Urology. 2006 May;67(5):1079-83
16635508
Urologe A. 2008 Sep;47(9):1173-4
18679649
J Endourol. 2008 May;22(5):1071-6
18429683
World J Urol. 2008 Dec;26(6):531-7
18846378